BlackRock’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Buy |
2,319,166
+1,463,858
| +171% | +$16.3M | ﹤0.01% | 2815 |
|
|
2025
Q1 | $10.5M | Buy |
855,308
+109,180
| +15% | +$1.34M | ﹤0.01% | 3253 |
|
|
2024
Q4 | $8.35M | Buy |
746,128
+41,379
| +6% | +$463K | ﹤0.01% | 3473 |
|
|
2024
Q3 | $4.91M | Buy |
704,749
+33,874
| +5% | +$236K | ﹤0.01% | 3656 |
|
|
2024
Q2 | $5.07M | Buy |
670,875
+596,721
| +805% | +$4.51M | ﹤0.01% | 3631 |
|
|
2024
Q1 | $979K | Sell |
74,154
-12,348
| -14% | -$163K | ﹤0.01% | 4143 |
|
|
2023
Q4 | $892K | Buy |
86,502
+26,534
| +44% | +$274K | ﹤0.01% | 4219 |
|
|
2023
Q3 | $583K | Buy |
59,968
+23,851
| +66% | +$232K | ﹤0.01% | 4317 |
|
|
2023
Q2 | $162K | Buy |
36,117
+3,646
| +11% | +$16.4K | ﹤0.01% | 4701 |
|
|
2023
Q1 | $151K | Sell |
32,471
-2,076
| -6% | -$9.63K | ﹤0.01% | 4779 |
|
|
2022
Q4 | $51.5K | Buy |
34,547
+9,101
| +36% | +$13.6K | ﹤0.01% | 5137 |
|
|
2022
Q3 | $95K | Buy |
25,446
+3,360
| +15% | +$12.5K | ﹤0.01% | 5101 |
|
|
2022
Q2 | $109K | Sell |
22,086
-313,116
| -93% | -$1.55M | ﹤0.01% | 5128 |
|
|
2022
Q1 | $2.75M | Sell |
335,202
-4,885
| -1% | -$40.1K | ﹤0.01% | 4172 |
|
|
2021
Q4 | $3.43M | Buy |
340,087
+6,113
| +2% | +$61.6K | ﹤0.01% | 4100 |
|
|
2021
Q3 | $5.29M | Sell |
333,974
-521
| -0.2% | -$8.26K | ﹤0.01% | 3879 |
|
|
2021
Q2 | $7.96M | Buy |
+334,495
| New | +$7.96M | ﹤0.01% | 3660 |
|